‘Fast-acting’ insulin and insulin aspart with ‘closed loop’ delivery were compared in type 1 diabetes care. Fast-acting insulin was modestly better.
People diagnosed with type 2 diabetes can eventually achieve normal glucose levels. But whether or when this means a person is “in remission” was the subject of an international group of experts convened by the American Diabetes Association.
Researchers sought to identify which medications for type 2 diabetes may be associated with severity of COVID-19.
The researchers tested whether daily fiber supplementation in addition to fecal microbial transplantation would improve cardiometabolic outcomes among severely obese patients.
A team of researchers investigated the effect of interventions to overcome therapeutic inertia regarding glycemic control in patients with type 2 diabetes.
The researchers examined the relationships of T2D all-cause mortality and myocardial infarction with prior HbA1c values and explored the potential impact of instituting earlier glucose-lowering therapy.
Researchers sought to evaluate the role of insulin administration method on glycemic control, hypoglycemia risk, treatment adherence, and quality of life in older adults with type 2 diabetes.
The researchers hypothesized that as the participants became older adults, their cognitive functioning would decline more steeply relative to earlier assessments.
This retrospective cohort study assessed hospitalized patients with diabetes to see if the new ISF-based scales improved glycemic control vs a traditional single sliding scale.
A team of investigators conducted a population-based cohort study to determine whether preeclampsia history affected the relative risk for incident stroke.
